157 related articles for article (PubMed ID: 8392842)
1. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
2. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
3. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
4. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
Fairbank M; St-Pierre P; Nabi IR
Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
6. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
7. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Lotan R; Amos B; Watanabe H; Raz A
Cancer Res; 1992 Sep; 52(18):4878-84. PubMed ID: 1325286
[TBL] [Abstract][Full Text] [Related]
8. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
9. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Timar J; Silletti S; Bazaz R; Raz A; Honn KV
Int J Cancer; 1993 Dec; 55(6):1003-10. PubMed ID: 8253518
[TBL] [Abstract][Full Text] [Related]
10. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
[TBL] [Abstract][Full Text] [Related]
11. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Funasaka T; Haga A; Raz A; Nagase H
Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
[TBL] [Abstract][Full Text] [Related]
12. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Silletti S; Timar J; Honn KV; Raz A
Cancer Res; 1994 Nov; 54(22):5752-6. PubMed ID: 7954394
[TBL] [Abstract][Full Text] [Related]
13. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
Watanabe H; Carmi P; Hogan V; Raz T; Silletti S; Nabi IR; Raz A
J Biol Chem; 1991 Jul; 266(20):13442-8. PubMed ID: 1649192
[TBL] [Abstract][Full Text] [Related]
14. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
15. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
Tímár J; Rásó E; Döme B; Ladányi A; Bánfalvi T; Gilde K; Raz A
Clin Exp Metastasis; 2002; 19(3):225-32. PubMed ID: 12067203
[TBL] [Abstract][Full Text] [Related]
17. Species specificity of the cytokine function of phosphoglucose isomerase.
Amraei M; Nabi IR
FEBS Lett; 2002 Aug; 525(1-3):151-5. PubMed ID: 12163179
[TBL] [Abstract][Full Text] [Related]
18. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
19. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
20. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]